SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-024444
Filing Date
2017-12-01
Accepted
2017-12-01 15:02:11
Documents
3
Period of Report
2017-11-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ANNUAL MTG mygn-8k_20171130.htm 8-K 123366
2 EX-10.1 2017 EQUITY COMPENSATION PLAN mygn-ex101_17.htm EX-10.1 103318
3 EX-10.2 2013 EXECUTIVE INCENTIVE PLAN mygn-ex102_44.htm EX-10.2 71392
  Complete submission text file 0001564590-17-024444.txt   299347
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 171233970
SIC: 2835 In Vitro & In Vivo Diagnostic Substances